Related Experiment Video
Updated: Sep 19, 2025

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Extensive natural variation in bacterial ribosomal drug-binding sites
Chinenye L Ekemezie1, Lewis I Chan1, Charlotte R Brown1
1Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Bacterial ribosome drug-binding sites show extensive, lineage-specific diversity, not just in Escherichia coli. This natural variation explains antibiotic resistance and guides new drug development for targeted pathogen treatment.
Area of Science:
- Microbiology
- Evolutionary Biology
- Drug Discovery
Background:
- Bacterial ribosomes have drug-binding sites crucial for antibiotic action.
- Divergent drug-binding sites in bacteria can lead to natural antibiotic resistance or hypersensitivity.
- Previous studies lacked systematic analysis of this divergence across bacterial species.
Purpose of the Study:
- To reconstruct the evolutionary history of drug-binding residues in bacterial ribosomes.
- To determine the prevalence of divergent ribosomal drug-binding sites across bacterial species.
- To understand the implications of this diversity for antibiotic resistance and development.
Main Methods:
- Phylogenetic reconstruction of evolutionary history for rRNA drug-binding residues.
- Comparative analysis of ribosomal drug-binding site structures across diverse bacterial lineages.
- Phenotypic assessment of antibiotic resistance in bacteria with divergent sites.
Main Results:
- Many residues considered bacterial-specific are conserved only in subsets of bacteria.
- Divergent ribosomal drug-binding sites are widespread, stemming from ancient rRNA polymorphisms.
- Bacteria with divergent sites exhibit intrinsic resistance to relevant ribosome-targeting antibiotics.
Conclusions:
- Bacterial ribosome drug-binding sites exhibit extensive lineage-specific diversity.
- This diversity arises from conserved polymorphisms at the drug-binding interface.
- Findings provide a resource for developing targeted antibiotics and personalized pathogen treatment strategies.
Related Concept Videos
Ligand Binding and Linkage
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Development of Antibiotic Resistance

